Follow us on:
Breaking News
March 27, 2026
CP Direct: Friday Edition
Breaking News
FederalEquipment_ENL_0326_650x90

Merck Agrees to Acquire Terns for $6.7B

 
Merck Agrees to Acquire Terns for $6.7B

Expands its presence in hematology with TERN-701, a potential best-in-class candidate for the treatment of certain patients with chronic myeloid leukemia.
Read More >>

Top Headlines

Breaking News

Schreiner MediPharm Develops Transparent Deep-Freeze Seal

Reliably adheres in deep-freeze conditions while enabling irreversible first-opening indication.

SPONSOR

[LIVE EVENT] Enhancing Bioprocess Productivity through Modern Machine Learning Methods

In this webinar on April 15, learn how modern ML improves bioprocess productivity. Seongjin Kim of Samsung Biologics shows how XGBoost, Bayesian optimization, and explainable AI identify key process variables and drive data-driven performance gains.

Breaking News

Novartis Agrees to Acquire Excellergy

The proposed acquisition adds Exl-111, a half-life extended, high-affinity anti-IgE antibody in Phase 1.

Breaking News

Hoth Therapeutics Launches OpenClaw AI for Accelerating Drug Discovery

The platform can integrate preclinical and clinical datasets in real time, enhancing research execution.

SPONSOR

[WATCH NOW] Flexible Innovation for Complex Molecules

In this Contract Pharma VideoBite, Evotec’s team reveals how flexible innovation is unlocking improved solubility and bioavailability for complex molecules across modern drug development.

Breaking News
Promotions & Moves

Sygnature Discovery Taps Susanne Back to Lead In Vivo Pharmacology Team

Back has held senior scientific and leadership roles at Orion Pharma and Charles River.

Online Exclusives

Inside Simtra’s Growth Strategy

Franco Negron, CEO, Simtra BioPharma Solutions, on the company’s strategic expansion, the market forces behind Simtra’s growth, workplace development and more.

SPONSOR

Follow the Data to Grow: Why a Scientific Data Platform is Essential

Innovation is the engine that powers a company’s growth and product development, and for enterprises with R&D laboratories, those lab environments are the greatest source of this innovation.

Featured Resources

Solution Center SPOTLIGHT

Formulated Solutions

Formulated Solutions is a leading North American CDMO, specializing in Rx, OTC, and medical devices. With 600+ experts and 800,000 sq. ft. across two sites, we develop, manufacture, and package topicals, nasal sprays, liquids, and aerosols. Our proprietary technologies power brands in 40+ countries, delivering innovation at scale since 1999.

 

Solution Center SPOTLIGHT

INCOG BioPharma Services

INCOG BioPharma is a global fill/finish CDMO providing end-to-end solutions for clinical through commercial phase sterile injectable drug products. Our facility is FDA approved, Annex 1 compliant, and uses the latest technology to provide tailored manufacturing solutions. We fill into syringes, vials, and cartridges, and offer autoinjector assembly, final packaging solutions, and in-house analytics. Our experienced team creates value for customers by decreasing manufacturing times and simplifying complex supply chains, enabling drug developers to focus on advancing their therapies with confidence.